Esperion Therapeutics, Inc. (ESPR)
3.13
0.00 (0.00%)
USD |
NASDAQ |
May 21, 16:00
3.13
0.00 (0.00%)
After-Hours: 19:59
Esperion Therapeutics Accounts Payable (Quarterly) : 68.41M for March 31, 2026
Accounts Payable (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Accounts Payable (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.863B |
| Nektar Therapeutics | 10.03M |
| Harrow, Inc. | 26.12M |
| Corcept Therapeutics, Inc. | 33.31M |
| Eli Lilly & Co. | 5.029B |